Question

What is the success rate of stem cell therapy for Intellectual Disability?

No universal cell-therapy success rate exists for intellectual disability. Causes, baseline function, age, products and outcomes differ. Review the exact diagnosis and prespecified adaptive or functional measures, comparator, assessor blinding, denominators and complete follow-up.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Intellectual Disability

Cell, neural and exosome proposals remain cause- and product-specific research. Small uncontrolled reports cannot separate treatment from development, education, therapy, expectation or measurement bias. The FDA patient information states that unapproved regenerative products require proper clinical oversight and reports serious harms. Any proposal should start with an accurate diagnosis, genomic or metabolic assessment when indicated and an authorised protocol reviewed by an independent developmental specialist.

Am I a candidate? → · Intellectual Disability: full overview → · Intellectual Disability cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information